These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 3345042

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways.
    Miadonna A, Tedeschi A, Arnoux B, Sala A, Zanussi C, Benveniste J.
    Am Rev Respir Dis; 1989 Jul; 140(1):142-7. PubMed ID: 2546468
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P, Tillie-Leblond I, Malaquin F, Durieu J, Wallaert B, Tonnel AB.
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [Abstract] [Full Text] [Related]

  • 5. Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis.
    Braunstein G, Fajac I, Lacronique J, Frossard N.
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):630-5. PubMed ID: 1716429
    [Abstract] [Full Text] [Related]

  • 6. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls.
    de Graaf-in t Veld C, Garrelds IM, Koenders S, Gerth van Wijk R.
    Clin Exp Allergy; 1996 Aug; 26(8):903-8. PubMed ID: 8877155
    [Abstract] [Full Text] [Related]

  • 7. Study of the effects of paf-acether on human nasal airways.
    Leggieri E, Tedeschi A, Lorini M, Bianco A, Miadonna A.
    Allergy; 1991 Aug; 46(6):466-71. PubMed ID: 1720286
    [Abstract] [Full Text] [Related]

  • 8. Relationship between nasal resistance and airway hyperreactivity following nasal provocation with Dermatophagoides pteronyssinus in allergic rhinitis.
    Tsai JJ, Ho CY, Wang SR.
    Int Arch Allergy Immunol; 1995 Mar; 106(3):286-90. PubMed ID: 7888791
    [Abstract] [Full Text] [Related]

  • 9. Applicability and reproducibility of biomarkers for the evaluation of anti-inflammatory therapy in allergic rhinitis.
    Boot JD, Chandoesing P, de Kam ML, Mascelli MA, Das AM, Gerth van Wijk R, de Groot H, Verhoosel R, Hiemstra PS, Diamant Z.
    J Investig Allergol Clin Immunol; 2008 Mar; 18(6):433-42. PubMed ID: 19123434
    [Abstract] [Full Text] [Related]

  • 10. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold.
    Avila PC, Abisheganaden JA, Wong H, Liu J, Yagi S, Schnurr D, Kishiyama JL, Boushey HA.
    J Allergy Clin Immunol; 2000 May; 105(5):923-32. PubMed ID: 10808173
    [Abstract] [Full Text] [Related]

  • 11. Nasal response to capsaicin in patients with allergic rhinitis and in healthy volunteers: effect of colchicine.
    Roche N, Lurie A, Authier S, Dusser DJ.
    Am J Respir Crit Care Med; 1995 Apr; 151(4):1151-8. PubMed ID: 7697245
    [Abstract] [Full Text] [Related]

  • 12. Mediator release of neuropeptides after nasal provocation in perennial allergic rhinitis patients.
    Gawlik R, DuBuske L.
    Rhinology; 2010 Jun; 48(2):206-10. PubMed ID: 20502762
    [Abstract] [Full Text] [Related]

  • 13. Nasal allergen challenge and mediators release.
    Carlos AG, Carlos ML, Ferreira MB, Santos AS, Santos MC, Pedro E.
    Allerg Immunol (Paris); 1997 Nov; 29(9):269-71. PubMed ID: 9435923
    [Abstract] [Full Text] [Related]

  • 14. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T, Garrelds IM, van Toorenenbergen AW, Mulder PG, Gerth van Wijk R, Boegheim JP.
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of threshold criteria for the nasal histamine challenge test in perennial allergic rhinitis.
    Kanthawatana S, Maturim W, Fooanant S, Manorot M, Trakultivakorn M.
    Asian Pac J Allergy Immunol; 1997 Jun; 15(2):65-9. PubMed ID: 9346268
    [Abstract] [Full Text] [Related]

  • 16. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms.
    Juliusson S, Pipkorn U, Karlsson G, Enerbäck L.
    J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 1):898-909. PubMed ID: 1281177
    [Abstract] [Full Text] [Related]

  • 17. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage.
    Lim MC, Taylor RM, Naclerio RM.
    Am J Respir Crit Care Med; 1995 Jan; 151(1):136-44. PubMed ID: 7812543
    [Abstract] [Full Text] [Related]

  • 18. Distilled water nasal provocation in hyperreactive patients.
    Baudoin T, Anzic SA, Kalogjera L.
    Am J Rhinol; 1999 Jan; 13(3):229-33. PubMed ID: 10392244
    [Abstract] [Full Text] [Related]

  • 19. The alteration of nasal resistance before and after local exposure to heated aerosol in perennial allergic rhinitis.
    Naito K, Miyata S, Baba R, Mamiya T, Senoh Y, Iwata S, Yokoyama N, Yamakawa S, Ibata K.
    Rhinology; 1999 Jun; 37(2):66-8. PubMed ID: 10416251
    [Abstract] [Full Text] [Related]

  • 20. Nerve growth factor expression and release in allergic inflammatory disease of the upper airways.
    Sanico AM, Stanisz AM, Gleeson TD, Bora S, Proud D, Bienenstock J, Koliatsos VE, Togias A.
    Am J Respir Crit Care Med; 2000 May; 161(5):1631-5. PubMed ID: 10806167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.